✦ LIBER ✦

Clinical Efficacy and Safety of Once-Weekly Glucagon-Like Peptide-1 Agonists in Development for Treatment of Type 2 Diabetes Mellitus in Adults

✍ Scribed by Tzefos, M.; Harris, K.; Brackett, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-Weekly Exenatide: An Extended-Durat

✍ Minze, Molly G.; Klein, Mary S.; Jernigan, Michelle J.; Wise, Stephen L.; Frugé, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

An overview of once-weekly glucagon-like

✍ S. Madsbad; U. Kielgast; M. Asmar; C. F. Deacon; S. S. Torekov; J. J. Holst 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

The development of non-peptide glucagon-

✍ Ho-Sang Moon; Mi-Kyung Kim; Moon-Ho Son 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 620 KB

Glucagon-like peptide-1 receptor agonist

✍ Lund, Asger; Knop, Filip K.; Vilsbøll, Tina 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 484 KB

A review of efficacy and safety data reg

✍ Eduard Montanya; Giorgio Sesti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 193 KB

A glucagon-like peptide-1 (GLP-1) recept

✍ S. K. Thondam; D. J. Cuthbertson; B. S. Aditya; I. A. MacFarlane; J. P. Wilding; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB